IDH2 and central nervous system cancer: In 2016 WHO classification, codeletion of chromosomal arms 1p/19q (1p/19q codeletion) and isocitrate dehydrogenase 1 or 2 (IDH1 or IDH2) were included in diagnostic typing for glioma classification (56).